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Age-Dependent Glycosylation of the
Sodium Taurocholate Cotransporter
Polypeptide: From Fetal to Adult
Human Livers
Camillo Sargiacomo,1 Hoda El-Kehdy,1 Guillaume Pourcher,2 Bruno Stieger,3 Mustapha Najimi,1 and Etienne Sokal1
Sodium taurocholate cotransporter polypeptide (NTCP), mainly expressed on the sinusoidal membrane of hepatocytes, is
one of the major transporters responsible for liver bile acid (BA) re-uptake. NTCP transports conjugated BA from the
blood into hepatocytes and is crucial for correct enterohepatic circulation. Studies have shown that insufﬁcient hepatic
clearance of BA correlates with elevated serum BA in infants younger than 1 year of age. In the current study, we investigated
human NTCP messenger RNA and protein expression by using reverse-transcription quantitative polymerase chain reaction
and immunoblotting in isolated and cryopreserved human hepatocytes from two different age groups, below and above 1 year
of age. Here, we show that NTCP messenger RNA expression is not modulated whereas NTCP protein posttranslational gly-
cosylation is modulated in an age-dependent manner. These results were conﬁrmed by quantiﬁcation analysis of NTCP 55-
kDa N-glycosylated bands, which showed signiﬁcantly less total NTCP protein in donors below 1 year of age compared to
donors older than 1 year. NTCP tissue localization was also analyzed by means of immunoﬂuorescence. This revealed that
NTCP cellular localization in fetal samples was mainly perinuclear, suggesting that NTCP is not glycosylated, while its post-
natal localization on the plasma membrane is age dependent compared to multidrug resistant protein 2, which is apical starting
in fetal life. Conclusion: After birth, the NTCP age-dependent maturation process requires approximately 1 year to complete
NTCP glycosylation in human hepatocytes. Therefore, NTCP late posttranslational glycosylation appears to be important for
correct NTCP membrane localization, which might explain physiologic cholestasis in neonatal life and might play a central
role for HBV infection after birth. (Hepatology Communications 2018;2:693-702)
The liver is responsible for the transport ofsolutes from the portal venous circulation tothe canaliculus by bile acid (BA) vectorial
transport. Solute carrier transporters are crucial for an
active vectorial BA uptake.(1,2) Among these, the
sodium taurocholate cotransporter polypeptide (NTCP;
SLC10A1) is a major BA uptake transporter in the liver
that preferentially moves conjugated BA into mature
hepatocytes in a sodium-dependent manner.(3-5) In
humans, NTCP accounts for more than 80% of the
hepatic uptake of bile salts (Na1-dependent path-
way).(6-8) Alternatively, isoforms of the organic anion
Abbreviations: AFP, alpha-fetoprotein; BA, bile acid; CYP, cytochrome P450; mRNA, messenger RNA; MRP2, multidrug resistance protein 2;
NTCP, sodium taurocholate cotransporter polypeptide; PHH, primary human hepatocyte; PNGase F, peptide-N4-(N-acetyl-beta-glucosaminyl); qPCR,
quantitative polymerase chain reaction; RIPA, radio immunoprecipitation assay; SDS, sodium dodecyl sulfate; a-SMA, alpha smooth muscle actin.
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transporting polypeptides multispeciﬁc transporter fam-
ily compensate for NTCP deﬁciency by internalizing
conjugated and unconjugated BA (Na1-independent
pathway).(9,10) Patients with primary hypercholanemia
have been described with relatively mild clinical pheno-
types, which have also been associated with growth
retardation and vitamin deﬁciency.(11,12) Interestingly,
down-regulation of plasma membrane NTCP was
reported in cases of progressive familial intrahepatic
cholestasis-2 and -3(13) and was thought to be linked to
NTCP posttranslational modiﬁcations.
Structurally speaking, NTCP is a 55-kDa N-glyco-
sylated multipass transmembrane protein composed of
349 amino acids that shares over 70% sequence simi-
larity with rat Ntcp.(14,15) On the N-terminal domain,
two N-linked glycosylation sites (Asn 5, Asn 11)
facing the extracellular lumen have been character-
ized(15,16) and are important for NTCP localization
on the plasma membrane.(17) Current knowledge of
NTCP ontogenesis is mostly based on experiments
conducted on rats and shows that i) compared to adult
levels, Ntcp messenger RNA (mRNA) levels at birth
are 35%-76%; ii) in newborns, Ntcp protein expression
reaches adult levels during the ﬁrst postnatal week; iii)
Ntcp expression levels and plasma membrane localiza-
tion do not correlate with protein functional status; iv)
NTCP activity is delayed approximately 4 weeks after
birth.(6,18-21) However, extrapolations in humans are
limited due to the known differences among species in
NTCP expression regulation. In this work, NTCP
gene and protein expression in fetal, neonatal, infant,
and adult livers were investigated to better understand
human NTCP ontogeny. Here, we found by immuno-
blotting analysis that the NTCP glycosylation process
is completed after approximately 1 year of age. We
measured NTCP 55 kDa total protein amounts
between hepatocyte samples above and below 1 year of
age and found that donors younger than 1 year
expressed signiﬁcantly lower amounts of mature
NTCP protein compared to donors older than 1 year
and adults. Then, we again show by immuno-
ﬂuorescence analysis that NTCP protein is gradually
expressed on the plasma membrane in an age-
dependent manner and is absent on the hepatocyte
surface of fetal livers. Overall, these ﬁndings show
for the ﬁrst time that NTCP N-glycosylation requires
several months to completely functionally localize on
the plasma membrane of mature hepatocytes.
Materials and Methods
CRYOPRESERVED PRIMARY
HUMAN HEPATOCYTES
Twelve isolated hepatocyte specimens from donors
with no known NTCP-related pathology were obtained
from the human liver and liver stem cell tissue bank,
Center for Tissular and Cellular Therapy, Cliniques
Universitaires St. Luc (Brussels, Belgium). Consent to
use the tissue for research was obtained from the legal
guardians (Table 1). Human fetal livers were carefully
dissected from fetuses collected after voluntary preg-
nancy termination at gestational weeks 12-13 with the
mothers’ written consent, abiding by the French ethical
guidelines and the amended Declaration of Helsinki.
Hepatocyte isolation was performed by using two-
step collagenase perfusion under good manufacturing
practice-like conditions.(22-25) The isolated hepatocytes
were stored in liquid nitrogen until use. Batches of cry-
opreserved hepatocytes were rapidly thawed in a 378C
water bath and washed twice using thawing solution.
After two centrifugations at 400g for 5 minutes at 48C,
hepatocyte pellets of approximately 5 million and
50 million cells were suspended in lysis buffer speciﬁc
for RNA or protein analysis.
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NTCP mRNA EXPRESSION
ANALYSIS
Total RNA extraction was performed by dissolving
cell pellets with Tripure reagent (Roche, Belgium).
Approximately 2 lg of total RNA were reverse tran-
scribed by the High Capacity complementary DNA
(cDNA) Reverse Transcription Kit (Life Technologies,
Belgium). For each quantitative polymerase chain reac-
tion (qPCR), a total of 25 ng input cDNA was analyzed
in duplicate by TaqMan gene expression assays (Table 2).
DDCt comparative analysis was used to evaluate the
expression of genes encoding multidrug resistance protein
2 (MRP2), cytochrome P450 3A4 (CYP3A4),
CYP7A1, alpha-fetoprotein (AFP), alpha smooth muscle
actin (a-SMA), and by using the peptidylprolyl isomerase
A housekeeping gene as control. Primary human hepato-
cytes (PHHs) from a 3-day-old donor were used as the
reference sample. Results are expressed for all tested genes
as mRNA increase (expressed as fold increase compared
to reference sample [Donor 7, 3 days old]).
WESTERN BLOTTING
Total protein lysates were obtained by dissolving cell
pellets from 5 million-10 million PHHs in radio
immunoprecipitation assay (RIPA) lysis buffer (50
mM Tris base, pH 8.0, 150 mM NaCl, 1% Triton X-
100, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate
[SDS]) supplemented with a cocktail of protein inhibi-
tors (Roche). Samples were then vortexed, left on ice
for a few minutes, sonicated with an Ultrasonicator
homogenizer (Sonopuls) for at least 30 seconds, and
incubated for an additional 30 minutes at 48C. Clariﬁ-
cation was performed by centrifugation at maximum
speed (20,800 rcf) for 15 minutes. Pellets were resus-
pended in RIPA buffer for protein quantiﬁcation analy-
sis. Fifty micrograms of PHH samples were boiled in
loading buffer (100 mM Tris-HCl [pH 6.8], glycerol
4% [volume fvol.g/vol.], SDS [weight/vol.], dithiothrei-
tol 200 mM, bromophenol blue 0.2%) at 958C for 5
minutes. Protein gel separation was performed using a
10% Tris-glycine SDS-polyacrylamide gel electrophore-
sis gel that was then blotted overnight onto polyvinyli-
dene ﬂuoride membranes. Membranes were then
blocked for 1 hour using 5% bovine serum albumin
blocking solution and subsequently incubated overnight
at 48C in blocking solution containing rabbit anti-
NTCP (1:1,000).(26) Fluorescent-labeled secondary anti-
bodies (Biotium) were then used for 40 minutes at room
temperature. Revelation was accomplished by the Odys-
sey imaging system (LI-COR). Image Studio Light 4
software (LI-COR) was used for quantiﬁcation analysis.
PNGase DEGLYCOSYLATIONASSAY
Peptide-N4-(N-acetyl-beta-glucosaminyl) (PNGase
F) asparagine amidase de-glycosylation treatment (New
England Biolabs) was performed according to the man-
ufacturer’s instructions with slight modiﬁcations. PHH
total protein extracts were treated with PNGase F con-
taining RIPA buffer for 2 hours at 388C.
IMMUNOFLUORESCENCE ASSAY
Five micrometer-thick human liver sections (paraf-
ﬁn embedded) at different age stages were deparafﬁ-
nized and rehydrated in graded alcohol. For antigen
retrieval, liver sections were incubated in citric acid
monohydrate buffer (Dako), then microwaved for 10
minutes at 720 W. Nonspeciﬁc staining was prevented
by incubating the slices in 10% bovine serum albumin
for 45 minutes at room temperature. Slices were incu-
bated with anti-NTCP at 1:100 (HP A042727;
Sigma) and anti-MRP2 at 1:50 (ALX-801-016-C250;
TABLE 1. CHARACTERISTICS OF THE TWO LIVER
DONOR GROUPS USED IN THE CURRENT STUDY
FOR IMMUNOBLOTTING
Donor Above 1 Year of Age Age Sex
1 2 years old F
2 3 years old F
3 3 years old M
4 4 years old F
5 14 years old M
6 26 years old F
Donor Below 1 Year ff Age Age Sex
7 3 days old M
8 6 days old F
9 1 month old M
10 4 months old M
11 7 months old F
12 1 year old M
TABLE 2. TAQMAN PROBES USED FOR GENE
EXPRESSION ANALYSIS
Gene Reference Supplier
NTCP Hs00161820_m1 ThermoFisher
MRP2 Hs00960489_m1 ThermoFisher
CYP3A4 Hs00604506_m1 ThermoFisher
CYP7A1 Hs00167982_m1 ThermoFisher
a-SMA Hs00559403_m1 ThermoFisher
AFP Hs01040598_m1 ThermoFisher
PPIA Hs99999904_m1 ThermoFisher
Abbreviation: PPIA, peptidylprolyl isomerase A.
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Enzo) primary antibodies overnight at 48C. After the
washing step, slices were incubated for 1 hour with
donkey anti-rabbit at 1:500 (A10042; Invitrogen) and
then for one hour with donkey anti-mouse at 1:500
(A31571; Invitrogen) secondary antibodies at room
temperature. Nuclei were stained for 5 minutes with
4’,6-diamidino-2-phenylindole (Life Technologies).
Slides were mounted in Fluoromount medium (Dako).
Fluorescence was assessed using an Imager A1 ﬂuores-
cence microscope (Carl Zeiss), and digital images were
acquired using Axiovision software.
STATISTICAL ANALYSIS
Statistical analysis was performed using GraphPad
PRISM 6 software. The Student t test and Mann-
Whitney U test were used. P < 0.01 was considered
signiﬁcant. All values are expressed as mean 6 SEM
or median.
Results
NTCP mRNA LEVELS ARE NOT
DIFFERENTIALLY MODULATED
BELOW AND ABOVE 1 YEAR
OF AGE
NTCP age-dependent transcriptional modulation
was analyzed by measuring the expression of the
NTCP gene together with a series of liver-speciﬁc and
control genes in hepatocyte donors above and below 1
year of age by reverse-transcription qPCR (Fig. 1).
Our results showed that expression of typical hepatic
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FIG. 1. Hepatocyte relative gene expression analysis. Gene expression analysis of hepatocytes below and above one year of age: NTCP
(31 6 26.0 versus 97 6 63.7), MRP2 (1.3 6 0.23 versus 2.4 6 0.6), CYP3A4 (474.6 6 296.0 versus 2,184 6 1,195), and CYP7A1
(6.1 6 7.8 versus 10.8 6 19.0); relative gene expression did not signiﬁcantly increase with age. The expression of genes encoding nonhe-
patic markers AFP (0.6 6 0.8 versus 0.02 6 0.02) and a-SMA (2.470 6 1.638 versus 1.803 6 1.020) was nonsigniﬁcantly decreased in
donors above 1 year of age. Intravariability was elevated in both groups. Values are expressed as mRNA fold increase versus controls
(3-day-old donor) and represent median 6 SEM. Peptidylprolyl isomerase A was used as the housekeeping reference gene, and hepato-
cytes from the youngest donor were used as the reference sample. Statistical analysis was performed by the one-tail Mann-Whitney test
(P > 0.1). Median values are represented with a black horizontal line in each box plot. Abbreviation: ns, not signiﬁcant.
                                                                                                                                      
SARGIACOMO ET AL. HEPATOLOGY COMMUNICATIONS, June 2018
696
markers MRP2, CYP3A4, and CYP7A1 or other fetal
AFP and mesenchymal a-SMA genes were not signiﬁ-
cantly different between the two groups, mainly due to
the intravariability in the mRNA expression levels
between donors of the same group. However, com-
pared to donors less than 1 year old, the median values
of NTCP (younger than 1 year, 31 6 26.07 versus
older than 1 year, 97 6 63.71), MRP2 (1.3 6 0.2
versus 2.4 6 0.5), and CYP3A4 (474.6 6 296.0 versus
2,184 6 1,195) data suggested a trend toward
enhanced gene expression in hepatocytes above 1 year
of age. In contrast, relative gene expression of AFP
(0.63 6 0.89 versus 0.02 6 0.02) and a-SMA (2.47 6
1.63 versus 1.80 6 1.02) showed, as expected, to be
strongly decreased in hepatocytes older than 1 year
compared to those younger than 1 year. Remarkably,
expression during development of the CYP7A1
hepatic marker for bile salt synthesis was virtually iden-
tical (6.15 6 7.84 versus 10.83 6 19.04) in
hepatocytes younger and older than 1 year, which sug-
gests an early onset of bile salt synthesis.
NTCP 55 kDA GLYCOSYLATED
BAND IS MODULATED BY AGE
We next investigated NTCP protein expression by
western blotting analysis. We ﬁrst validated the
NTCP primary antibody and conﬁrmed that, com-
pared to a negative control of HepG2 cells, hepatocytes
from 2 donors, aged 3 years and 6 days, expressed
NTCP (Fig. 2A). Glycosylated and nonglycosylated
NTCP forms resulted in multiple bands ranging from
35 to 65 kDa that were detected in hepatocytes sam-
ples but not in HepG2 cells. Intriguingly, these results
indicate that while 35-kDa nonglycosylated NTCP
bands were stably expressed in both samples, 55-kDa
glycosylated NTCP bands increased in aged donors
(Supporting Fig. S1). Moreover, compared with
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FIG. 2. NTCP immunoblotting and N-glycosylation in hepatocytes. (A) Fifty micrograms of hepatocyte total protein extracts from infant (3
years) and neonate (6 days) donors were compared with HepG2 cells by immunoblotting analysis. Anti-NTCP antibody was able to detect
multiple NTCP bands (complex glycosylation 55-kDa and nonglycosylated 35-kDa bands). HepG2 cells did not express NTCP protein. (B)
Immunoblotting assay showing NTCP deglycosylation by PNGase F between hepatocytes and HepG2 cells. NTCP complex glycosylation 55
kDa was validated for its N-glycosylation sites. (C) NTCP amino acid structure and transmembrane domains in the plasma membrane (Uni-
prot sequence, Q14973). Depicted are ﬁve asparagine residues (green circles), two of which, Asp 5 and 11, are N-glycosylated.
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untreated samples, NTCP 55-65-kDa N-glycosylated
bands were effectively deglycosylated with PNGase F
and produced a band shift to 35 kDa (Fig. 2A;
Supporting Fig. S2). HepG2 cells did not express
NTCP, and PNGase digestion did not produce any
molecular weight shift in the NTCP bands.
COMPLETION OF NTCP
GLYCOSYLATION REQUIRES
AT LEAST 1 YEAR
Subsequently, we analyzed hepatocyte samples from
6 donors less than 1 year and 6 donors older than
1 year by immunoblotting and densitometry (Fig. 3).
Compared to donors below 1 year, NTCP 55-65-kDa
bands were highly expressed in samples above 1 year
and were conﬁrmed by PNGase treatment compared
to nontreated samples (P 5 0.0032) (Fig. 3). In
contrast, we found that NTCP glycosylation of
hepatocytes below 1 year was poor and that compared
to untreated samples, PNGase F treatment failed to
increase NTCP total protein (P 5 0.5). We also
observed that NTCP nonglycosylated protein pools
(untreated lanes) were comparable between donors
below and above 1 year of age, suggesting a stable
quantity of the native NTCP protein pool.
NTCP AND MRP2 ARE
DIFFERENTIALLY REGULATED
DURING LIVER DEVELOPMENT
Human liver sections from fetal donors and infants
older and younger than 1 year were analyzed by immu-
noﬂuorescence to study NTCP localization and to
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FIG. 3. NTCP immunoblotting and total protein quantiﬁcation analysis. NTCP immunoblotting analysis of treated and untreated hepa-
tocyte samples with PNGase. NTCP complex glycosylated 55-kDa bands were efﬁciently digested and resulted in an almost complete
band shift of the NTCP signal to a single band at 35 kDa (NTCP total protein) that was quantiﬁed in neonate and infant donors below 1
year of age and infants and adults above 1 year of age. (A) NTCP total protein was signiﬁcantly increased in treated donors above 1 year of
age compared to untreated donors (P 5 0.0032). (B) In contrast, treated and untreated hepatocyte samples of donors less than 1 year of
age showed no differences (P 5 0.5), consistent with poor NTCP glycosylation in infants. Values are expressed as NTCP 35 kDa net sig-
nal. Statistical unpaired t test (two-tailed) was performed (P < 0.01). Results are expressed as net signal. Horizontal black lines are the
mean of the quantiﬁed amount. Abbreviation: ns, not signiﬁcant.
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investigate if the lack of glycosylation revealed by
immunoblotting correlates with an effective reduction
of NTCP membranous expression between prenatal
and postnatal stages (n 5 5) (Fig. 4). We found that
postnatally, NTCP protein expression was relatively
low and, when detected, was mainly localized in the
cytoplasm, as observed in liver samples below 1 year of
age. However, compared to mature livers where
NTCP is found on the plasma membrane, less
immunostaining was detected in a 4-year-old donor.
Indeed, to our knowledge, this is the ﬁrst time that
NTCP localization has been reported to be found
mainly in the cell cytoplasm of fetal hepatocytes (Fig. 5).
In contrast, MRP2 localization in fetal hepatocytes
appeared with a sharp linear canalicular staining similar
to mature liver but with a more linear canalicular struc-
ture (Fig. 6); no cytoplasm localization was observed
during development, indicating that NTCP and MRP2
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FIG. 4. NTCP immunoﬂuorescence in fetal, neonate, and infant liver tissues. Liver tissue samples were analyzed by immunoﬂuores-
cence (n 5 5). Each row represents 1 donor. Columns starting from left show nuclear staining using DAPI (blue), NTCP staining
(red), and merged staining (blue/red). In fetal livers, NTCP localization was mainly intracytoplasmic. Compared to prenatal samples,
6-day-old and 4-month-old donors in postnatal condition showed increased NTCP expression; NTCP plasma localization at 1 and 4
years of age is almost exclusively found on the plasma membrane (magniﬁcation 3200). Abbreviations: DO, days old; MO, months
old; DAPI, 4’,6-diamidino-2-phenylindole; YO, years old.
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are differentially regulated at different developmental
stages.
Discussion
Immediately following birth, numerous and dra-
matic changes occur in hepatic blood ﬂow and in
the structural and functional organization of the
liver.(27) Our study suggests that NTCP protein N-
glycosylation is age dependent and is not completed
until approximately 1 year after birth. In contrast, Ntcp
glycosylation in rats was shown to be completed within
4 weeks after birth, illustrating signiﬁcant species differ-
ences in transporter expression, as described.(28,29)
Additionally, by using immunoﬂuorescence, our study
revealed that the adult NTCP membrane pattern
was reached only after 1 year of age and was strongly
correlated with the net increase of the NTCP 55-kDa
complex glycosylated band previously detected by
immunoblotting analysis in hepatocytes older than
1 year. In contrast, MRP2 is already located at the api-
cal membrane of hepatocytes in fetal and neonatal liver
samples, indicating different regulation mechanisms for
these transporters during development.
Our ﬁndings are also supported by clinical data sug-
gesting that “physiologic cholestasis” is caused by imma-
ture posttranslational glycosylation modiﬁcations of
NTCP.(30,31) Under physiological conditions, the fetus
presents a low serum BA pool (0.1 mM) that increases
postnatally (1-2 mM). These drastic changes after birth
indicate that BA clearance compensatory activity by the
placenta is lost in the fetus and that liver clearance func-
tions are insufﬁcient in most neonates.(28,32) Clinical evi-
dence shows in most cases that serum BA levels reach
adult values (0.5 mM) only after 1 year of age, again sup-
porting the increase in NTCP glycosylation demon-
strated in our study (Figs. 3 and 6). In general, BA
concentration levels in plasma are an indirect marker for
cholestasis in neonates. It was previously shown in
infants that total conjugated chenodeoxycholate blood
levels are elevated before 1 year of age, thus suggesting
that hepatic clearance of BAs is progressively enhanced
during human development by increasing the number of
membranous hepatobiliary transporters.(33) A more
recent study using high-performance liquid chromatog-
raphy analysis demonstrated that total serum bile salt
levels in the blood before 1 year of age are 90% higher
than after 1 year of age.(34) Overall, these studies are con-
sistent with our ﬁndings suggesting that incomplete
NTCP glycosylation might be responsible for hypercho-
lanemia in early infancy.
Furthermore, we found that NTCP protein was
mainly localized in the cytoplasm of fetal livers and
was absent from the surface of immature hepatocytes
(Fig. 5), which suggests a key compensatory BA
uptake activity by the placenta BA transporters. We
also show in Fig. 6 that MRP2 distribution in neo-
nates and infants is exclusively localized at the apical
membrane and is absent from the cytoplasm, which is
in line with other studies conducted on human fetal
liver samples.(35) These results indicate a different reg-
ulation between MRP2 and NTCP protein expression
and conﬁrm that the hepatocyte maturation process
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FIG. 5. NTCP and MRP2 distribution in human fetal and
infant liver tissues. Liver tissues co-immunostained with NTCP
(red) and MRP2 (green) were analyzed in fetal (n 5 2) and post-
natal (n 5 3) livers and counterstained with DAPI. NTCP local-
ization in fetal and neonatal hepatocytes was found in the
cytoplasm; NTCP localization becomes more expressed on the
surface of hepatocytes with age. In contrast, MRP2 distribution
was found to be expressed apically and was not found in the
cytoplasm (magniﬁcation 3200). Abbreviations: DO, days old;
MO, months old; DAPI, 4’,6-diamidino-2-phenylindole; YO,
years old.
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toward a fully polarized transporter phenotype is a late
event with respect to NTCP.
Transporter glycosylation is differentially regulated
by the liver–gut axis pathway, i.e., BA, cortisol, and
other soluble agents from the diet or secreted by gut
ileocytes.(9) In vitro studies have shown that dexameth-
asone increases NTCP mRNA and protein expression
by glucocorticoid receptor activation.(36,37) Therefore,
it would be interesting to investigate the impact of
dexamethasone on NTCP glycosylation, particularly
after NTCP functional characterization as the ﬁrst
hepatitis B virus receptor.(38) In addition to glycosyla-
tion, other NTCP posttranslational modiﬁcations
might participate in modulating NTCP subcellular
localization during development. In particular, phos-
phorylation/dephosphorylation, a cyclic adenosine
monophosphate-dependent process, regulates NTCP
localization in mature hepatocytes.(1,39) It would now
be interesting to investigate how phosphorylation/
dephosphorylation regulates NTCP localization in
fetal hepatocytes. In conclusion, NTCP glycosylation
is completed within 1 year after birth and could be
used as a potential clinical diagnostic marker for neo-
nates suffering from high BA plasma levels and studied
in the context of HBV infection.
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